Dexcom Inc

DXCMNASDAQ · USD
87.73USD0.00 (-2.01%)
679

Dexcom Inc (DXCM) Implied Volatility Current

DXCM implied volatility is 35%. IV Rank is 9%, placing current premiums in the bottom of their 52-week range.

Read more

Tracking DXCM implied volatility helps you identify when options premiums on Dexcom Inc are historically cheap or expensive, and where the best trades are hiding. Dexcom Inc implied volatility reflects the market's expectation of future price movement: when DXCM IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Dexcom Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For DXCM, tracking metrics like DXCM IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on DXCM signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system.

The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where DXCM implied volatility sits today versus where it has been. Our scanner ranks Dexcom Inc implied volatility against its historical range, surfaces extremes in DXCM IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Dexcom Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
9.13%IV Rank
Low

IV is compressed vs the past year - options are relatively cheap, favoring buyers.

Implied Volatility (30d)35.14%

IV Rank9.13%

Historical Volatility (30d)23.74%

IV - HV+11.40%

As of September 23, 2026

Trade options with IV on your side

Track DXCM IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial